Authored By: Sarah
18 Jun 2024

 Drug Discovery Informatics Market to grow by USD 7287.7 million between 2024-2028

According to a research report “ Drug Discovery Informatics Market” by Application (Discovery informatics, Development informatics) Solution (Software, Services) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 7287.7 million at a CAGR of over 18.17% during the forecast period. In light of the escalating burden of chronic diseases, such as diabetes, COPD, asthma, cancer, heart diseases, arthritis, cystic fibrosis, and dementia, affecting over 60% of US adults (CDC), the pharmaceutical and biopharmaceutical sectors are prioritizing Research and Development (R&D) efforts to expand their pipelines with innovative drug molecules. Focus areas include immunology, oncology, and infectious diseases. This trend underscores the growing significance of Drug Discovery Informatics, which facilitates the efficient identification, optimization, and development of potential therapeutics..

Browse market data tables, figures, and in-depth TOC on “Drug Discovery Informatics Market” by Application (Discovery informatics, Development informatics) Solution (Software, Services) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028.

 View detailed Table of Content- Click here

By Application, the Discovery informatics segment is projected to dominate the market size in 2024.

In the realm of Drug Discovery Informatics, Artificial Intelligence (AI) is revolutionizing the industry through algorithms and software, enabling analysis of intricate medical data without human intervention. Recent advancements in AI technologies have significantly boosted NLP and machine learning applications for drug discovery, leading to increased productivity, reduced costs, and shorter development timelines. The integration of AI tools is primarily driven by factors such as streamlined processes, heightened safety and efficacy predictions, and the opportunity to diversify drug pipelines. The burgeoning advancement in drug discovery platforms is further fueling market growth over the forecast period.

By Solution, Software  segment is expected to hold the largest market size for the year 2024.

In the dynamic landscape of drug discovery and development, the role of Drug Discovery Informatics Market assumes significance. This market facilitates the efficient handling of vast data generated during the identification and validation of lead compounds. Leveraging advanced technologies such as high-throughput screening, molecular modeling, medicinal chemistry, and structural biology, Drug Discovery Informatics Market aids in the early-stage lead generation process, thereby streamlining the drug discovery process and enhancing overall productivity.

North America is forecasted to hold the largest market size by region in 2024.

In the dynamic realm of Drug Discovery Informatics, businesses leverage advanced technologies to optimize research and development processes. By integrating data-driven insights and AI-powered tools, organizations can streamline workflows, enhance productivity, and reduce costs. This market is characterized by continuous innovation, with a focus on improving drug discovery efficiency and accuracy.

The Drug Discovery Informatics Market t growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Aragen Life Sciences Pvt. Ltd.
  • Certara Inc.
  • Charles River Laboratories International Inc.
  • ChemAxon Ltd.
  • ChemBridge Corp.
  • Collaborative Drug Discovery Inc.
  • Cresset BioMolecular Discovery Ltd.
  • Curia Global Inc.
  • Dassault Systemes SE
  • Eurofins Scientific SE
  • Evotec SE
  • Infosys Ltd.
  • Insilico Medicine
  • International Business Machines Corp.
  • Jubilant Pharmova Ltd.
  • Melissa Inc.
  • OpenEye Scientific Software Inc.
  • PerkinElmer Inc.
  • Schrodinger Inc.
  • Selvita SA
  • Thermo Fisher Scientific Inc.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

In the dynamic and innovative biotechnology industry, Drug Discovery Informatics has emerged as a critical domain, leveraging technological advancements to streamline the process of identifying and developing novel medications for various diseases, particularly those classified as rare or orphan. This market encompasses the utilization of molecular modeling, genome sequencing data, proteins, and nucleic acids to analyze sequences, design clinical trials, and profile both genes and patients. Bioinformatic solutions and sequence analysis platforms are essential tools in this field, enabling data gathering, visualization, and storage. Informatics software facilitates data management and analysis, ensuring the effectiveness of medical care and precision medicine. Orphan drug research and rare disease studies significantly benefit from these informatics applications, as they often involve complex genetic profiling and molecular modeling. The Drug Discovery Informatics Market plays a pivotal role in the development of traditional procedures and novel medications, contributing to the overall progress of the pharmaceutical sector. By harnessing the power of data-driven insights, this market is revolutionizing the way we approach drug discovery and development.

Market Research Overview

The Drug Discovery Informatics Market encompasses the use of specialized expertise, bioinformatics solutions, and informatics software for target discovery sequencing, Hit-to-lead optimization, Hit discovery, Molecular modeling, and computational drug discovery. This market leverages artificial intelligence, AI algorithms, and high-performance computing to analyze large datasets of genome sequencing data, genes, proteins, and nucleic acids. The market caters to medical scientists, academics, and researchers in the healthcare industry, focusing on chronic diseases, novel therapeutic compounds, and treatments for cancer and infectious diseases. Infrastructure investments in hardware, financial investments in informatics solutions, and cloud-based technology enable the processing, storage, and data mining of drug development data. The market also supports clinical trial design, drug molecules, and in-silico modeling tools, as well as data visualization and data gathering for precision medicines and orphan drug research. Technological advancements in molecular profiling, genetic profiling, and patient groups contribute to the effectiveness of medical care and the development of innovative pharmaceuticals.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio